The global pharmaceutical electronic manufacturing services market is projected to grow from USD 32.69 billion in 2025 to USD 51.91 billion by 2031, at a compound annual growth rate of 8.10%. North America held 46.36% of the market in 2025, while Asia-Pacific is forecast to grow fastest at an 11.24% CAGR. PCB assembly and integration accounted for 40.13% of revenue in 2025, and pharmaceutical manufacturing equipment electronics represented 42.27%. Jabil reported 14% growth in its healthcare segment in 2025 and acquired Pharmaceutics International in February 2025 to expand aseptic filling and lyophilization capabilities. High capital requirements for cleanrooms and automated assembly lines remain a key barrier to entry.
Jabil Circuit IncJabil's healthcare segment grew 14% and it acquired Pharmaceutics International to expand capabilities, benefiting from EMS market growth.
